Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ANDREW PANAKOS

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1427491364
CMS profile
2781736
Location
BOCA RATON, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$2,303.49

115 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,182.61 112
Education $120.88 3

By paying entity

PY2022 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 115 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ANDREW PANAKOS

NPI 1427491364 · CMS profile ID 2781736

Allopathic & Osteopathic Physicians / Internal Medicine / Cardiovascular Disease

BOCA RATON, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 115 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1427491364?year=2022&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ANDREW PANAKOS, NPI 1427491364, CMS profile ID 2781736. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 115 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1427491364?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). ANDREW PANAKOS, NPI 1427491364, CMS profile ID 2781736. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 115 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1427491364?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
ANDREW PANAKOS, NPI 1427491364, CMS profile ID 2781736, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 115 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1427491364?year=2022&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

115 matching records · $2,303.49 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 115 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 115.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Bayer HealthCare Pharmaceuticals Inc. $15.6207/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929958111 CMS
Novartis Pharmaceuticals Corporation $6.3207/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894196581 CMS
PFIZER INC. $19.0207/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949207647 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $11.0007/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 876351935 CMS
AstraZeneca Pharmaceuticals LP $14.2007/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915608241 CMS
Amgen Inc. $21.9906/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939198285 CMS
Alnylam Pharmaceuticals Inc. $21.1106/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 926066141 CMS
Janssen Pharmaceuticals, Inc $12.1606/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885903109 CMS
Merck Sharp & Dohme LLC $16.7606/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944200373 CMS
Amgen Inc. $7.8706/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939198283 CMS
SANOFI-AVENTIS U.S. LLC $23.1906/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939108547 CMS
PFIZER INC. $22.1606/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949165887 CMS
Amgen Inc. $10.3906/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939198273 CMS
Abbott Laboratories $39.2006/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920467491 CMS
Novartis Pharmaceuticals Corporation $14.0606/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894196577 CMS
PFIZER INC. $24.8606/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949183605 CMS
Janssen Pharmaceuticals, Inc $17.5605/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885903079 CMS
Novartis Pharmaceuticals Corporation $3.2805/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894196573 CMS
PFIZER INC. $21.4005/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949139311 CMS
ABIOMED $145.1505/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942067451 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $8.8705/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 876351929 CMS
Novartis Pharmaceuticals Corporation $20.5505/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894196565 CMS
Boston Scientific Corporation $12.2005/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 916710075 CMS
Bayer HealthCare Pharmaceuticals Inc. $14.6004/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930189827 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $25.0804/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887431007 CMS
Amarin Pharma Inc. $19.5404/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 913900881 CMS
Novartis Pharmaceuticals Corporation $11.0404/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894196569 CMS
Amgen Inc. $14.4704/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939198281 CMS
Novartis Pharmaceuticals Corporation $14.7104/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894196557 CMS
PFIZER INC. $21.4004/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949110419 CMS
Janssen Pharmaceuticals, Inc $16.4904/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885903073 CMS
Novartis Pharmaceuticals Corporation $10.6104/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894196561 CMS
Abbott Laboratories $23.7703/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 910327151 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $9.9003/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 876351933 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.3803/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887398903 CMS
AstraZeneca Pharmaceuticals LP $14.7403/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914996255 CMS
Abbott Laboratories $13.4303/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920466367 CMS
Abbott Laboratories $35.0003/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 920466373 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $9.4103/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 876351931 CMS
SANOFI-AVENTIS U.S. LLC $19.2703/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939108513 CMS
Novartis Pharmaceuticals Corporation $8.7803/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894196553 CMS
Amgen Inc. $5.2903/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939198279 CMS
Astellas Pharma US Inc $17.0003/07/2022 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940137721 CMS
Astellas Pharma US Inc $89.9903/07/2022 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940137725 CMS
Bayer HealthCare Pharmaceuticals Inc. $18.3903/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930175335 CMS
Amgen Inc. $12.9003/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939198277 CMS
PFIZER INC. $22.5802/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949062525 CMS
Chiesi USA, Inc. $13.1302/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 960792413 CMS
Novartis Pharmaceuticals Corporation $9.7202/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 894196549 CMS
PFIZER INC. $21.4002/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949065553 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,344.16 25
PY2020 $1,912.72 20
PY2021 $2,851.92 127
PY2022 $2,303.49 115
PY2023 $3,789.61 102
PY2024 $4,362.81 140
PY2025 $2,157.64 115

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $73,195.48 22
PY2024 Principal investigator $26,692.00 4

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

22 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $5,439.00 12/15/2025 Non-covered Recipient Entity
Fwd Clinic Rsrch
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175200294
Principal investigator 1 Janssen Research & Development, LLC $472.00 12/12/2025 Non-covered Recipient Entity
Fwd Clinic Rsrch
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175200985
Principal investigator 1 Janssen Research & Development, LLC $1,500.00 12/04/2025 Non-covered Recipient Entity
Fwd Clinic Rsrch
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175200544
Principal investigator 1 Janssen Research & Development, LLC $2,857.00 11/21/2025 Non-covered Recipient Entity
Fwd Clinic Rsrch
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175200455
Principal investigator 1 PFIZER INC. $562.72 10/30/2025 Non-covered Recipient Entity
FWD Clinical Research
A PHASE 2 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF AN ORAL BRANCHEDCHAIN KETOACID DEHYDROGENASE KINASE INHIBITOR PF07328948 IN ADULTS WITH HEART FAILURE BRANCHHF No dispute reported 06/30/2026 1228812447
Principal investigator 1 Janssen Research & Development, LLC $1,155.00 10/22/2025 Non-covered Recipient Entity
Fwd Clinic Rsrch
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175200587
Principal investigator 1 Janssen Research & Development, LLC $820.00 09/19/2025 Non-covered Recipient Entity
Fwd Clinic Rsrch
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175200383
Principal investigator 1 Janssen Research & Development, LLC $300.00 09/03/2025 Non-covered Recipient Entity
Fwd Clinic Rsrch
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175200173
Principal investigator 1 Janssen Research & Development, LLC $1,007.00 08/25/2025 Non-covered Recipient Entity
Fwd Clinic Rsrch
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175200718
Principal investigator 1 Janssen Research & Development, LLC $86.00 08/22/2025 Non-covered Recipient Entity
Fwd Clinic Rsrch
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175200931
Principal investigator 1 PFIZER INC. $23,600.00 08/22/2025 Non-covered Recipient Entity
FWD Clinical Research
A PHASE 2 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF AN ORAL BRANCHEDCHAIN KETOACID DEHYDROGENASE KINASE INHIBITOR PF07328948 IN ADULTS WITH HEART FAILURE BRANCHHF No dispute reported 06/30/2026 1228842747
Principal investigator 1 AstraZeneca Pharmaceuticals LP $18,526.76 08/07/2025 Non-covered Recipient Entity
FWD CLINICAL RESEARCH
A Phase III Randomised Doubleblind Study to Evaluate the Effect of Balcinrenone Dapagliflozin Compared with Dapagliflozin on the Risk of Heart Failure Events and Cardiovascular Death in Patients with Heart Failure and Impaired Kidney Function No dispute reported 06/30/2026 1185550881
Principal investigator 1 Janssen Research & Development, LLC $1,453.00 07/23/2025 Non-covered Recipient Entity
Fwd Clinic Rsrch
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175200638
Principal investigator 1 Janssen Research & Development, LLC $816.00 06/26/2025 Non-covered Recipient Entity
Fwd Clinic Rsrch
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175200874
Principal investigator 1 Janssen Research & Development, LLC $2,950.00 06/25/2025 Non-covered Recipient Entity
Fwd Clinic Rsrch
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175200569
Principal investigator 1 Janssen Research & Development, LLC $258.00 06/20/2025 Non-covered Recipient Entity
Fwd Clinic Rsrch
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175200851
Principal investigator 1 Janssen Research & Development, LLC $2,646.00 05/23/2025 Non-covered Recipient Entity
Fwd Clinic Rsrch
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175200314
Principal investigator 1 Janssen Research & Development, LLC $1,453.00 05/16/2025 Non-covered Recipient Entity
Fwd Clinic Rsrch
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175200708
Principal investigator 1 Janssen Research & Development, LLC $962.00 04/23/2025 Non-covered Recipient Entity
Fwd Clinic Rsrch
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175200925
Principal investigator 1 Janssen Research & Development, LLC $1,711.00 03/17/2025 Non-covered Recipient Entity
Fwd Clinic Rsrch
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175200652
Principal investigator 1 Janssen Research & Development, LLC $1,413.00 02/24/2025 Non-covered Recipient Entity
Fwd Clinic Rsrch
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175200898
Principal investigator 1 Janssen Research & Development, LLC $3,208.00 01/22/2025 Non-covered Recipient Entity
Fwd Clinic Rsrch
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) No dispute reported 06/30/2026 1175200842